Apoptosis and long non-coding RNAs: Focus on their roles in Heart diseases

被引:5
|
作者
Al-Masri, Abeer [1 ]
机构
[1] King Saud Univ, Coll Med, Dept Physiol, Riyadh 11451, Saudi Arabia
关键词
Apoptosis; Diabetic cardiomyopathy; Heart failure; Aging heart; Myocardial ischemia; INDUCED CARDIOMYOCYTE APOPTOSIS; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; DYNAMIN-RELATED PROTEIN-1; DOXORUBICIN-INDUCED APOPTOSIS; INHIBITS CELL-PROLIFERATION; OXIDATIVE STRESS; PROTECTS CARDIOMYOCYTES; SIGNALING PATHWAY; TUMOR-SUPPRESSOR;
D O I
10.1016/j.prp.2023.154889
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Heart disease is one of the principal death reasons around the world and there is a growing requirement to discover novel healing targets that have the potential to avert or manage these illnesses. On the other hand, apoptosis is a strongly controlled, cell removal procedure that has a crucial part in numerous cardiac problems, such as reperfusion injury, MI (myocardial infarction), consecutive heart failure, and inflammation of myocardium. Completely comprehending the managing procedures of cell death signaling is critical as it is the primary factor that influences patient mortality and morbidity, owing to cardiomyocyte damage. Indeed, the prevention of heart cell death appears to be a viable treatment approach for heart illnesses. According to current researches, a number of long non-coding RNAs cause the heart cells death via different methods that are embroiled in controlling the activity of transcription elements, the pathways that signals transmission within cells, small miRNAs, and the constancy of proteins. When there is too much cell death in the heart, it can cause problems like reduced blood flow, heart damage after restoring blood flow, heart disease in diabetics, and changes in the heart after reduced blood flow. Therefore, studying how lncRNAs control apoptosis could help us find new treatments for heart diseases. In this review, we present recent discoveries about how lncRNAs are involved in causing cell death in different cardiovascular diseases.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Long Non-coding RNAs in Pathogenesis of Neurodegenerative Diseases
    Zhou, Shiyue
    Yu, Xiao
    Wang, Min
    Meng, Yujie
    Song, Dandan
    Yang, Hui
    Wang, Dewei
    Bi, Jianzhong
    Xu, Shunliang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [42] Kidney diseases and long non-coding RNAs in the limelight
    Liu, Chenxin
    Ma, Kuai
    Zhang, Yunchao
    He, Xing
    Song, Linjiang
    Chi, Mingxuan
    Han, Zhongyu
    Li, Guanhua
    Zhang, Qinxiu
    Liu, Chi
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [43] The role of long non-coding RNAs in rheumatic diseases
    Yuanjia Tang
    Tian Zhou
    Xiang Yu
    Zhixin Xue
    Nan Shen
    Nature Reviews Rheumatology, 2017, 13 : 657 - 669
  • [44] Long Non-Coding RNAs and Complex Human Diseases
    Li, Jing
    Xuan, Zhenyu
    Liu, Changning
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (09) : 18790 - 18808
  • [45] Non-coding RNAs and diseases
    Y. Huang
    J. P. Wang
    X. L. Yu
    Z. B. Wang
    T. S. Xu
    X. C. Cheng
    Molecular Biology, 2013, 47 : 465 - 475
  • [46] Non-coding RNAs and diseases
    Huang, Y.
    Wang, J. P.
    Yu, X. L.
    Wang, Z. B.
    Xu, T. S.
    Cheng, X. C.
    MOLECULAR BIOLOGY, 2013, 47 (04) : 465 - 475
  • [47] The non-coding skin: Exploring the roles of long non-coding RNAs in epidermal homeostasis and disease
    Hombach, Sonja
    Kretz, Markus
    BIOESSAYS, 2013, 35 (12) : 1093 - 1100
  • [48] Long Non-coding RNAs: At the Heart of Cardiac Dysfunction?
    Hobuss, Lisa
    Baer, Christian
    Thum, Thomas
    FRONTIERS IN PHYSIOLOGY, 2019, 10
  • [49] Nanoplastics: Focus on the role of microRNAs and long non-coding RNAs
    Banikazemi, Zarrin
    Farshadi, Mojgan
    Rajabi, Ali
    Homayoonfal, Mina
    Sharifi, Nasrin
    Chaleshtori, Reza Sharafati
    CHEMOSPHERE, 2022, 308
  • [50] The Expanding Roles of Long Non-Coding RNAs in Pancreatic Cancer
    Yan, Yu
    Wu, Danzhu
    Yang, Liyuan
    Han, Jinming
    Liu, Yinglong
    Dong, Peng
    Wu, Jing
    Yu, Xinshuang
    ADVANCED THERAPEUTICS, 2023, 6 (12)